- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02664701
Cognitive Behavioural Group Therapy Versus Individual Supportive Therapy for the Prevention of Repeat Suicide Attempts (G-PACTS)
Cognitive Behavioural Group Therapy Versus Individual Supportive Therapy for the Prevention of Repeat Suicide Attempts: a Multicentre, Assessor-blinded, 2-parallel-group, Randomised, Superiority Trial
Study Overview
Status
Conditions
Detailed Description
The secondary objectives of this study are to assess the efficacy of CBGT on:
A. parameters describing the incidence of suicide and repeat suicide attempts, as well as suicide re-attempt free follow-up time,
B. long-term changes in suicidal ideation,
C. long-term changes in psychiatric symptoms (depression, hope for the future, hospitalization).
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Mocrane Abbar, MD
- Phone Number: +33.(0)4.66.68.34.26
- Email: mocrane.abbar@chu-nimes.fr
Study Contact Backup
- Name: Carey Suehs, PhD
- Phone Number: +33.(0)4.66.68.67.88
- Email: carey.suehs@chu-nimes.fr
Study Locations
-
-
-
Clermont Ferrand, France, 63003
- Not yet recruiting
- CHU de Clermont Ferrand - Hôpital Gabriel-Montpied
-
Principal Investigator:
- Pierre-Michel Llorca, MD, PhD
-
Lyon Cedex 3, France, 69437
- Not yet recruiting
- CHU de Lyon - Groupement Hospitalier Edouard Herriot
-
Principal Investigator:
- Emmanuel Poulet, MD, PhD
-
Montpellier, France, 34295
- Not yet recruiting
- CHRU de Montpellier - Hôpital Lapeyronie
-
Principal Investigator:
- Philippe Courtet, MD, PhD
-
Nîmes, France, 30000
- Not yet recruiting
- Clinique Les Sophoras
-
Principal Investigator:
- Stephane Torrès, MD
-
Nîmes Cedex 09, France, 30029
- Recruiting
- CHRU de Nîmes - Hôpital Universitaire Carémeau
-
Sub-Investigator:
- Mocrane Abbar, MD
-
Principal Investigator:
- Jorge Lopez Castroman, MD
-
Sub-Investigator:
- Laurent Chaïb, PhD, pschologist
-
Paris, France, 75674
- Recruiting
- CMME
-
Contact:
- FABRICE JOLLANT
- Phone Number: 0145658572
- Email: fjolllant@gmail.com
-
Poitiers, France, 86021
- Not yet recruiting
- CH Henri Laborit
-
Principal Investigator:
- Nematollah Jaafari, MD
-
Saint Cyr sur Loire, France, 37540
- Not yet recruiting
- CHRU de Tours - Clinique Psychiatrique Universitaire
-
Principal Investigator:
- Wissam El-Hage, MD
-
Strasbourg Cedex, France, 67091
- Not yet recruiting
- CHRU de Strasbourg - Hôpital Civil
-
Principal Investigator:
- Pierre Vidailhet, MD, PhD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- The patient has been correctly informed
- The patient must have given his/her informed and signed consent
- The patient must be insured or beneficiary of a health insurance plan
- French speaking adults (18 years or older) freely hospitalized (in centres or via emergency services) for prevention of suicide and who have a medium or high suicide risk score according to a Mini International Neuropsychiatric Interview structured interview
- Presence of suicidal ideation according to the Beck Suicide Ideation Scale (score > 3)
- Prior (or recent) suicide attempt within the last three month
- The patient is able to understand the study and capable of giving his/her informed consent
- The patient is available during the weekly time slots proposed by the investigator
Exclusion Criteria:
- The patient is participating in another study that may interfere with the results or conclusions of this study
- Within the past three months, the patient has participated in another study that may interfere with the results or conclusions of this study
- The patient is in an exclusion period determined by a previous study
- The patient is under judicial protection, or is an adult under guardianship
- The patient refuses to sign the consent, or it is impossible to correctly inform the patient
- Emergency situations preventing proper study conduct
- History of schizophrenia or other psychotic troubles
- Presence of psychotic symptoms at initial interview
- Serious cognitive impairment
- Medical incapacity to participate
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Individual supportive therapy
Patients randomized to this arm will have individual supportive therapy. Intervention: Baseline evaluation with a psychiatrist Intervention: Individual supportive therapy Intervention: Evaluations with a psychiatrist |
Baseline data and questionnaires are established.
6 sessions of individual supportive therapy with a psychologist, 1 session per week for 6 weeks
Evaluation withs a psychiatrist in the 10 days following the end of psychotherapy, then at 3, 6, 9, and 12 months.
|
Experimental: Cognitive behavioural group therapy
Patients randomized to this arm will have cognitive behavioural therapy. Intervention: Baseline evaluation with a psychiatrist Intervention: Cognitive behavioural group therapy Intervention: Evaluations with a psychiatrist |
Baseline data and questionnaires are established.
Evaluation withs a psychiatrist in the 10 days following the end of psychotherapy, then at 3, 6, 9, and 12 months.
6 sessions of cognitive behavioural group therapy with a psychologist, 1 session per week for 6 weeks
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
The primary clinical endpoint is the duration (in days) of a suicide reattempt-free follow-up period
Time Frame: 12 months
|
12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The Columbia suicide severity rating scale (C-SSRS)
Time Frame: baseline
|
baseline
|
|
The Columbia suicide severity rating scale (C-SSRS)
Time Frame: in the 10 days after the end of psychotherapy
|
in the 10 days after the end of psychotherapy
|
|
The Columbia suicide severity rating scale (C-SSRS)
Time Frame: 3 months
|
3 months
|
|
The Columbia suicide severity rating scale (C-SSRS)
Time Frame: 6 months
|
6 months
|
|
The Columbia suicide severity rating scale (C-SSRS)
Time Frame: 9 months
|
9 months
|
|
The Columbia suicide severity rating scale (C-SSRS)
Time Frame: 12 months
|
12 months
|
|
Completed suicide (yes/no)
Time Frame: in the 10 days after the end of psychotherapy
|
in the 10 days after the end of psychotherapy
|
|
Completed suicide (yes/no)
Time Frame: 3 months
|
3 months
|
|
Completed suicide (yes/no)
Time Frame: 6 months
|
6 months
|
|
Completed suicide (yes/no)
Time Frame: 9 months
|
9 months
|
|
Completed suicide (yes/no)
Time Frame: 12 months
|
12 months
|
|
Number of suicide re-attempts during the follow-up period.
Time Frame: in the 10 days after the end of psychotherapy
|
A suicide attempt is defined as either an "actual attempt" or an "interrupted attempt" using the definitions in the C-SSRS assessment.
|
in the 10 days after the end of psychotherapy
|
Number of suicide re-attempts during the follow-up period.
Time Frame: 3 months
|
A suicide attempt is defined as either an "actual attempt" or an "interrupted attempt" using the definitions in the C-SSRS assessment.
|
3 months
|
Number of suicide re-attempts during the follow-up period.
Time Frame: 6 months
|
A suicide attempt is defined as either an "actual attempt" or an "interrupted attempt" using the definitions in the C-SSRS assessment.
|
6 months
|
Number of suicide re-attempts during the follow-up period.
Time Frame: 9 months
|
A suicide attempt is defined as either an "actual attempt" or an "interrupted attempt" using the definitions in the C-SSRS assessment.
|
9 months
|
Number of suicide re-attempts during the follow-up period.
Time Frame: 12 months
|
A suicide attempt is defined as either an "actual attempt" or an "interrupted attempt" using the definitions in the C-SSRS assessment.
|
12 months
|
Beck Suicide Ideation Scale (BSSI)
Time Frame: Baseline
|
Baseline
|
|
Beck Suicide Ideation Scale (BSSI)
Time Frame: in the 10 days after the end of psychotherapy
|
in the 10 days after the end of psychotherapy
|
|
Beck Suicide Ideation Scale (BSSI)
Time Frame: 3 months
|
3 months
|
|
Beck Suicide Ideation Scale (BSSI)
Time Frame: 6 months
|
6 months
|
|
Beck Suicide Ideation Scale (BSSI)
Time Frame: 9 months
|
9 months
|
|
Beck Suicide Ideation Scale (BSSI)
Time Frame: 12 months
|
12 months
|
|
Beck Depression Inventory-II (BDI-II)
Time Frame: Baseline
|
Baseline
|
|
Beck Depression Inventory-II (BDI-II)
Time Frame: in the 10 days after the end of psychotherapy
|
in the 10 days after the end of psychotherapy
|
|
Beck Depression Inventory-II (BDI-II)
Time Frame: 3 months
|
3 months
|
|
Beck Depression Inventory-II (BDI-II)
Time Frame: 6 months
|
6 months
|
|
Beck Depression Inventory-II (BDI-II)
Time Frame: 9 months
|
9 months
|
|
Beck Depression Inventory-II (BDI-II)
Time Frame: 12 months
|
12 months
|
|
Beck Hopelessness Scale (BHS)
Time Frame: Baseline
|
Baseline
|
|
Beck Hopelessness Scale (BHS)
Time Frame: in the 10 days after the end of psychotherapy
|
in the 10 days after the end of psychotherapy
|
|
Beck Hopelessness Scale (BHS)
Time Frame: 3 months
|
3 months
|
|
Beck Hopelessness Scale (BHS)
Time Frame: 6 months
|
6 months
|
|
Beck Hopelessness Scale (BHS)
Time Frame: 9 months
|
9 months
|
|
Beck Hopelessness Scale (BHS)
Time Frame: 12 months
|
12 months
|
|
Cumulative days of hospitalization
Time Frame: in the 10 days after the end of psychotherapy
|
in the 10 days after the end of psychotherapy
|
|
Cumulative days of hospitalization
Time Frame: 3 months
|
3 months
|
|
Cumulative days of hospitalization
Time Frame: 6 months
|
6 months
|
|
Cumulative days of hospitalization
Time Frame: 9 months
|
9 months
|
|
Cumulative days of hospitalization
Time Frame: 12 months
|
12 months
|
Collaborators and Investigators
Investigators
- Study Director: Mocrane Abbar, MD, Centre Hospitalier Universitaire de Nîmes
Publications and helpful links
General Publications
- Witt KG, Hetrick SE, Rajaram G, Hazell P, Taylor Salisbury TL, Townsend E, Hawton K. Psychosocial interventions for self-harm in adults. Cochrane Database Syst Rev. 2021 Apr 22;4(4):CD013668. doi: 10.1002/14651858.CD013668.pub2.
- Chaib LS, Lopez-Castroman J, Abbar M. Group Post-Admission Cognitive Therapy for Suicidality vs Individual Supportive Therapy for the prevention of repeat suicide attempts: a randomized controlled trial. Trials. 2020 Oct 27;21(1):889. doi: 10.1186/s13063-020-04816-y.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PHRC-N/2014/MA-01
- 2015-A01585-44 (Other Identifier: RCB number)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Suicidal Ideation
-
University of WashingtonUnited States Department of Defense; Military Suicide Research ConsortiumCompletedSuicidal and Self-injurious Behavior | Suicidal Ideation ActiveUnited States
-
The Catholic University of AmericaUniversity of Washington; VA Office of Research and DevelopmentCompletedSuicidal and Self-injurious Behavior | Suicidal Ideation Active
-
Emory UniversityGeorgia Institute of TechnologyCompletedSuicide, Suicidal IdeationUnited States
-
Henry M. Jackson Foundation for the Advancement...University of Pennsylvania; University of Michigan; Duke University; US Department... and other collaboratorsUnknownSuicide, Attempted | Suicidal Ideation ActiveUnited States
-
Technische Universität DresdenUnknownDepression | Suicidal Ideation/BehaviorGermany
-
International Islamic University, IslamabadRecruitingImpulsivity | Suicidal Ideation and BehaviorPakistan
-
VA Office of Research and DevelopmentCentral Texas Veterans Health Care SystemRecruitingHealth | Reintegration Difficulties | Suicidal Ideation and Behaviors | ConnectednessUnited States
-
Children's Hospital Medical Center, CincinnatiCompleted
-
Eisenhower Army Medical CenterAugusta University; The Geneva Foundation; Congressionally Directed Medical Research...CompletedSuicidal Ideation | Suicide | Suicidal Intention | Suicidal Impulses | Suicidal and Self-Injurious Behavior | Suicidal DepressionUnited States
-
Ohio State UniversityUniversity of Minnesota; Rutgers UniversityCompletedSuicidal Ideation | SuicidalUnited States
Clinical Trials on Baseline evaluation with a psychiatrist
-
Centre Hospitalier de ValenciennesCentre Oscar Lambret; Ligue contre le cancer, France; Centre de Cancérologie... and other collaboratorsRecruiting
-
Nantes University HospitalCR2TI, INSERM, UMR1064RecruitingBipolar Disorder I | Bipolar Disorder II | Schizoaffective Disorder, Depressive TypeFrance
-
Riphah International UniversityRecruiting
-
Centre Hospitalier Universitaire de NīmesCompletedDepression | Stress Disorders, Post-TraumaticFrance
-
University Hospital, MontpellierCompletedAttention Deficit Disorder | Emotional DysfunctionFrance
-
Coloplast A/SCompleted
-
University Hospital, RouenUnknown
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI); National Institutes of Health (NIH)CompletedHead Neck CancerUnited States
-
Riphah International UniversityCompletedMills Manipulation and Mulligan PRP Affect Pain, Grip Strength and Function on Lateral EpicondylitisLateral EpicondylitisPakistan
-
Assistance Publique - Hôpitaux de ParisThe Paul Bennetot FoundationCompletedModerate to Severe DementiaFrance